GSH-Activatable Metal-Phenolic Networks for Photothermal-Enhanced Chemotherapy and Chemodynamic Therapy
Chemotherapy (CT) plays an important role in the antitumor process, but the unsatisfactory therapeutic efficacy and the obvious toxic side effects of CT seriously restrict its application. To overcome the limitations of CT, the strategy of chemotherapy enhanced by chemodynamic therapy (CDT) and photothermal therapy (PTT) has been considered a promising approach to improve the anticancer effect. Herein, a novel GSH-activatable Cu2+-Quercetin network (QC) was synthesized via a convenient strategy to load Au nanoparticles (NPs) and DOX, named QCDA, for the synergistic therapy of CT/CDT/PTT. The results showed that QCDA exhibited GSH-sensitive degradation and "cargos" release in cancer cells, and then PTT and CDT caused by Au NPs and Cu+ significantly enhanced the CT effect of DOX and Quercetin on anticancer. More importantly, the PTT and depleted GSH accelerated the Fenton-like ionization process resulting in facilitating the CDT efficiency. Collectively, the multi-mode synergistic strategy of CT/CDT/PTT, which showed an excellent therapeutic effect, maybe a potential therapeutic pathway for anticancer.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Journal of functional biomaterials - 14(2023), 9 vom: 23. Aug. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Weijun [VerfasserIn] |
---|
Links: |
---|
Themen: |
Chemodynamic therapy |
---|
Anmerkungen: |
Date Revised 03.10.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jfb14090436 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362511764 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM362511764 | ||
003 | DE-627 | ||
005 | 20231227171620.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jfb14090436 |2 doi | |
028 | 5 | 2 | |a pubmed24n1208.xml |
035 | |a (DE-627)NLM362511764 | ||
035 | |a (NLM)37754850 | ||
035 | |a (PII)436 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Weijun |e verfasserin |4 aut | |
245 | 1 | 0 | |a GSH-Activatable Metal-Phenolic Networks for Photothermal-Enhanced Chemotherapy and Chemodynamic Therapy |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 03.10.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Chemotherapy (CT) plays an important role in the antitumor process, but the unsatisfactory therapeutic efficacy and the obvious toxic side effects of CT seriously restrict its application. To overcome the limitations of CT, the strategy of chemotherapy enhanced by chemodynamic therapy (CDT) and photothermal therapy (PTT) has been considered a promising approach to improve the anticancer effect. Herein, a novel GSH-activatable Cu2+-Quercetin network (QC) was synthesized via a convenient strategy to load Au nanoparticles (NPs) and DOX, named QCDA, for the synergistic therapy of CT/CDT/PTT. The results showed that QCDA exhibited GSH-sensitive degradation and "cargos" release in cancer cells, and then PTT and CDT caused by Au NPs and Cu+ significantly enhanced the CT effect of DOX and Quercetin on anticancer. More importantly, the PTT and depleted GSH accelerated the Fenton-like ionization process resulting in facilitating the CDT efficiency. Collectively, the multi-mode synergistic strategy of CT/CDT/PTT, which showed an excellent therapeutic effect, maybe a potential therapeutic pathway for anticancer | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a GSH-activatable | |
650 | 4 | |a chemodynamic therapy | |
650 | 4 | |a chemotherapy | |
650 | 4 | |a metal-phenolic networks | |
650 | 4 | |a photothermal therapy | |
700 | 1 | |a Yang, Meiyang |e verfasserin |4 aut | |
700 | 1 | |a Li, Jie |e verfasserin |4 aut | |
700 | 1 | |a Chen, Zhilan |e verfasserin |4 aut | |
700 | 1 | |a Hu, Lefei |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jiannan |e verfasserin |4 aut | |
700 | 1 | |a Cai, Liangyu |e verfasserin |4 aut | |
700 | 1 | |a Qiu, Lipeng |e verfasserin |4 aut | |
700 | 1 | |a Chen, Jinghua |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of functional biomaterials |d 2023 |g 14(2023), 9 vom: 23. Aug. |w (DE-627)NLM366234692 |x 2079-4983 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2023 |g number:9 |g day:23 |g month:08 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jfb14090436 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2023 |e 9 |b 23 |c 08 |